Protection against establishment of retroviral persistence by vaccination with a live attenuated virus

被引:25
作者
Dittmer, U [1 ]
Brooks, DM [1 ]
Hasenkrug, KJ [1 ]
机构
[1] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
关键词
D O I
10.1128/JVI.73.5.3753-3757.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Many human viruses not only cause acute diseases but also establish persistent infections. Such persistent viruses can cause chronic diseases or can reactivate to cause acute diseases in AIDS patients or patients receiving immunosuppressive therapies. While the prevention of persistent infections is an important consideration in the design of modern vaccines, surprisingly little is known about this aspect of protection. In the current study, we tested the feasibility of vaccine prevention of retroviral persistence by using a Friend virus model that we recently developed. In this model, persistent virus can be detected at very low levels by immunosuppressing the host to reactivate virus or by transferring persistently infected spleen cells into highly susceptible mice, Two vaccines were analyzed, a recombinant vaccinia virus vector expressing Friend virus envelope protein and a live attenuated Friend virus. Both vaccines reduced pathogenic virus loads to levels undetectable by infectious center assays, However, only the live, attenuated vaccine prevented immunosuppression-induced reactivation of persistent virus. Thus, even very low levels of persistent Friend virus posed a significant threat during immunosuppression, Our results demonstrate that vaccine protection against establishment of retroviral persistence is attainable.
引用
收藏
页码:3753 / 3757
页数:5
相关论文
共 32 条
[1]  
BRITT WJ, 1983, J IMMUNOL, V130, P2363
[2]   PERSISTENCE OF INFECTIOUS FRIEND-VIRUS IN SPLEENS OF MICE AFTER SPONTANEOUS-RECOVERY FROM VIRUS-INDUCED ERYTHROLEUKEMIA [J].
CHESEBRO, B ;
BLOOM, M ;
WEHRLY, K ;
NISHIO, J .
JOURNAL OF VIROLOGY, 1979, 32 (03) :832-837
[3]   HOST GENETIC-CONTROL OF RECOVERY FROM FRIEND LEUKEMIA VIRUS-INDUCED SPLENOMEGALY - MAPPING OF A GENE WITHIN MAJOR HISTOCOMPATABILITY COMPLEX [J].
CHESEBRO, B ;
WEHRLY, K ;
STIMPFLING, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 140 (06) :1457-1467
[4]   CHARACTERIZATION OF MONOCLONAL-ANTIBODIES REACTIVE WITH MURINE LEUKEMIA VIRUSES - USE IN ANALYSIS OF STRAINS OF FRIEND MCF AND FRIEND ECOTROPIC MURINE LEUKEMIA-VIRUS [J].
CHESEBRO, B ;
BRITT, W ;
EVANS, L ;
WEHRLY, K ;
NISHIO, J ;
CLOYD, M .
VIROLOGY, 1983, 127 (01) :134-148
[5]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[6]   Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection [J].
Chun, TW ;
Engel, D ;
Berrey, MM ;
Shea, T ;
Corey, L ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8869-8873
[7]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551
[8]  
delaTorre JC, 1996, ADV VIRUS RES, V46, P311
[9]   Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms [J].
Dittmer, U ;
Brooks, DM ;
Hasenkrug, KJ .
JOURNAL OF VIROLOGY, 1998, 72 (08) :6554-6558
[10]   Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection [J].
Dittmer, U ;
Brooks, DM ;
Hasenkrug, KJ .
NATURE MEDICINE, 1999, 5 (02) :189-193